Canaccord Genuity Group Trims Braze (NASDAQ:BRZE) Target Price to $50.00

Braze logo with Business Services background

Braze (NASDAQ:BRZE - Free Report) had its price objective lowered by Canaccord Genuity Group from $65.00 to $50.00 in a research report sent to investors on Monday, Benzinga reports. The brokerage currently has a buy rating on the stock.

Several other brokerages have also recently weighed in on BRZE. Raymond James decreased their price target on shares of Braze from $75.00 to $65.00 and set an outperform rating for the company in a research note on Thursday, March 28th. DA Davidson reaffirmed a buy rating and set a $65.00 price target on shares of Braze in a research note on Monday, March 25th. Piper Sandler reaffirmed an overweight rating and set a $66.00 price target on shares of Braze in a research note on Friday, April 5th. Scotiabank decreased their target price on shares of Braze from $65.00 to $58.00 and set a sector perform rating for the company in a research note on Thursday, March 28th. Finally, Needham & Company LLC reissued a buy rating and issued a $70.00 target price on shares of Braze in a research note on Thursday, March 28th. One investment analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of Moderate Buy and an average target price of $63.41.


Check Out Our Latest Research Report on Braze

Braze Stock Performance

NASDAQ BRZE traded up $0.74 during trading hours on Monday, reaching $39.68. 680,974 shares of the company's stock were exchanged, compared to its average volume of 860,172. The company's 50-day moving average is $50.00 and its two-hundred day moving average is $50.74. Braze has a one year low of $25.76 and a one year high of $61.53. The company has a market capitalization of $4.00 billion, a price-to-earnings ratio of -29.83 and a beta of 1.14.

Braze (NASDAQ:BRZE - Get Free Report) last issued its quarterly earnings results on Wednesday, March 27th. The company reported ($0.29) earnings per share for the quarter, topping the consensus estimate of ($0.31) by $0.02. The company had revenue of $130.96 million during the quarter, compared to analysts' expectations of $124.55 million. Braze had a negative net margin of 27.44% and a negative return on equity of 28.24%. Research analysts predict that Braze will post -1.18 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Braze news, insider Myles Kleeger sold 15,000 shares of Braze stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $56.96, for a total transaction of $854,400.00. Following the completion of the transaction, the insider now directly owns 244,291 shares of the company's stock, valued at $13,914,815.36. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, insider Myles Kleeger sold 15,000 shares of Braze stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $56.96, for a total transaction of $854,400.00. Following the completion of the sale, the insider now owns 244,291 shares of the company's stock, valued at $13,914,815.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Phillip M. Fernandez sold 1,500 shares of Braze stock in a transaction on Thursday, February 15th. The stock was sold at an average price of $59.91, for a total value of $89,865.00. Following the sale, the director now directly owns 11,056 shares of the company's stock, valued at approximately $662,364.96. The disclosure for this sale can be found here. Insiders sold a total of 77,815 shares of company stock valued at $4,164,679 over the last ninety days. 26.48% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Braze

A number of hedge funds and other institutional investors have recently modified their holdings of BRZE. 1832 Asset Management L.P. lifted its holdings in shares of Braze by 537.4% during the fourth quarter. 1832 Asset Management L.P. now owns 1,527,100 shares of the company's stock worth $81,135,000 after buying an additional 1,287,500 shares in the last quarter. Morgan Stanley raised its stake in Braze by 20.1% in the third quarter. Morgan Stanley now owns 5,387,736 shares of the company's stock valued at $251,769,000 after purchasing an additional 899,894 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its stake in Braze by 180.0% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,285,100 shares of the company's stock valued at $60,053,000 after purchasing an additional 826,100 shares in the last quarter. Invesco Ltd. raised its stake in Braze by 167.5% in the third quarter. Invesco Ltd. now owns 1,293,974 shares of the company's stock valued at $60,467,000 after purchasing an additional 810,295 shares in the last quarter. Finally, Norges Bank acquired a new position in Braze in the fourth quarter valued at about $37,584,000. Institutional investors and hedge funds own 90.47% of the company's stock.

About Braze

(Get Free Report)

Braze, Inc operates a customer engagement platform that provides interactions between consumers and brands worldwide. The company offers Braze software development kits that automatically manage data ingestion and deliver mobile and web notifications, in-application/in-browser interstitial messages, and content cards; REST API that can be used to import or export data or to trigger workflows between Braze and brands' existing technology stacks; Partner Data Integrations, which allow brands to sync user cohorts from partners; Data Transformation, in which brands can programmatically sync and transform user data; and Braze Cloud Data Ingestion that enables brands to harness their customer data.

Read More

Analyst Recommendations for Braze (NASDAQ:BRZE)

Should you invest $1,000 in Braze right now?

Before you consider Braze, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Braze wasn't on the list.

While Braze currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: